-transparent.png){kind=logo}
Vascular beta 2-adrenergic blocking effects of the water-soluble drugs atenolol (beta 1-selective) and nadolol (nonselective) were evaluated. Twenty-four healthy young men were studied in three dosing groups (eight subjects per group) before and after 1 wk on placebo, atenolol (50 mg twice a day), or nadolol (40 mg twice a day). Maximal treadmill exercise heart rates were reduced to a similar degree by atenolol (-48 +/- 3 bpm) and nadolol (-48 +/- 4 bpm) but were not affected by placebo. Trough blood levels were 226 +/- 9 ng/ml for atenolol and 43 +/- 9 ng/ml for nadolol. Calf blood flow was measured with a plethysmograph and calf vascular resistance was calculated from blood pressure and flow. beta 2-Adrenergic blockade was determined at rest with epinephrine infused intravenously in graded doses from 0.001 to 0.032 micrograms/kg/min. Mean arterial pressure and calf vascular resistance rose markedly after nadolol but not after atenolol or placebo. Marked bradycardia developed after nadolol, probably by baroreceptor stimulation. Thus at an equivalent, substantial degree of beta 1-adrenergic blockade, nadolol blocks vascular beta 2-adrenergic receptors and atenolol does not. Measurement of the peripheral vascular response to epinephrine infusion is an effective means of assessing the impact of beta-adrenergic blockers on vascular beta 2-adrenergic receptors.
W R Hiatt, and
E E Wolfel, and
S Stoll, and
A S Nies, and
G O Zerbe, and
H L Brammell, and
L D Horwitz
October 1984,
American heart journal,
W R Hiatt, and
E E Wolfel, and
S Stoll, and
A S Nies, and
G O Zerbe, and
H L Brammell, and
L D Horwitz
September 1990,
Anesthesiology,
W R Hiatt, and
E E Wolfel, and
S Stoll, and
A S Nies, and
G O Zerbe, and
H L Brammell, and
L D Horwitz
February 1987,
Cardiovascular research,
W R Hiatt, and
E E Wolfel, and
S Stoll, and
A S Nies, and
G O Zerbe, and
H L Brammell, and
L D Horwitz
July 1971,
European journal of pharmacology,
W R Hiatt, and
E E Wolfel, and
S Stoll, and
A S Nies, and
G O Zerbe, and
H L Brammell, and
L D Horwitz
January 1984,
Pharmacology,
W R Hiatt, and
E E Wolfel, and
S Stoll, and
A S Nies, and
G O Zerbe, and
H L Brammell, and
L D Horwitz
August 1968,
The Journal of pharmacology and experimental therapeutics,
W R Hiatt, and
E E Wolfel, and
S Stoll, and
A S Nies, and
G O Zerbe, and
H L Brammell, and
L D Horwitz
June 1976,
Canadian journal of physiology and pharmacology,
W R Hiatt, and
E E Wolfel, and
S Stoll, and
A S Nies, and
G O Zerbe, and
H L Brammell, and
L D Horwitz
April 1981,
The New England journal of medicine,
W R Hiatt, and
E E Wolfel, and
S Stoll, and
A S Nies, and
G O Zerbe, and
H L Brammell, and
L D Horwitz
September 1966,
The American journal of cardiology,
W R Hiatt, and
E E Wolfel, and
S Stoll, and
A S Nies, and
G O Zerbe, and
H L Brammell, and
L D Horwitz
April 1976,
Annals of surgery,
